Market Updates
MedImmune's Promise
kalina
01 Aug, 2002
New York City
-
Despite the uncertainty over the timeline for FluMist's approval by the FDA, MedImmune may still launch the vaccine during the 2002/2003 flu season and cheer investors.
Annual Returns
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|